SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BNB PLUS CORP. (BNBX) (CIK 0000744452) (BNBX) — Jan 15, 2025

BNB PLUS CORP. (BNBX) (CIK 0000744452)
Date: Jan. 15, 2025 · CIK: 0000744452 · Accession: 0001104659-25-003756

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-283315

Date
January 15, 2025
Author
Not clearly detected
Form
CORRESP
Company
BNB PLUS CORP. (BNBX) (CIK 0000744452)

Letter

Applied DNA Sciences, Inc.

50 Health Sciences Drive

Stony Brook, New York 11790

January 15, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

Re: Applied DNA Sciences, Inc.

Registration Statement on Form S-1

Filed November 19, 2024, as amended

File No. 333-283315

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-283315) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective on Friday, January 17, 2025 at 4:30 p.m. (Eastern Time), or as soon thereafter as practicable.

Please feel free to direct any questions or comments concerning this request to Todd Kornfeld, Esq. of McDermott Will & Emery LLP at (212) 547-5890.

The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

APPLIED DNA SCIENCES, INC.

By: /s/ James Hayward

Name: James Hayward

Title: Chief Executive Officer

cc: Todd Kornfeld, McDermott Will & Emery LLP

Show Raw Text
CORRESP
1
filename1.htm

Applied DNA Sciences, Inc.

50 Health Sciences Drive

Stony Brook, New York 11790

January 15, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

    Re:
    Applied DNA Sciences, Inc.

    Registration Statement on Form S-1

    Filed November 19, 2024, as amended

    File No. 333-283315

Ladies and Gentlemen:

Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effective date
of the Company’s Registration Statement on Form S-1 (File No. 333-283315) (the “Registration Statement”) be accelerated
so that the Company’s Registration Statement will become effective on Friday, January 17, 2025 at 4:30 p.m. (Eastern
Time), or as soon thereafter as practicable.

Please feel free to direct any
questions or comments concerning this request to Todd Kornfeld, Esq. of McDermott Will & Emery LLP at (212) 547-5890.

The Company understands that
the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is
aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration
Statement.

    APPLIED DNA SCIENCES, INC.

    By:
    /s/ James Hayward

    Name:
    James Hayward

    Title:
    Chief Executive Officer

cc: Todd Kornfeld, McDermott Will & Emery LLP